Professor Andrea Jorgensen PhD MSc BA ATT ATII

Professor, Biostatistics Health Data Science

    Publications

    Selected Publications

    1. A Randomized Trial of Genotype-Guided Dosing of Warfarin (Journal article - 2013)
    2. Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis (Journal article - 2012)
    3. Integration of genetic, clinical, and INR data to refine warfarin dosing (Journal article - 2010)
    4. Methodological quality of pharmacogenetic studies: Issues of concern (Journal article - 2008)
    5. Biomarker-guided trials: Challenges in practice (Journal article - 2019)
    6. Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials (Journal article - 2019)
    7. Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study (Journal article - 2019)
    8. NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis (Journal article - 2019)
    9. Association of variants within the GST and other genes with anti-tubercular agents related toxicity: a systematic review and meta-analysis (Journal article - 2019)
    10. CYP genetic variants and toxicity related to anti-tubercular agents: a systematic review and meta-analysis (Journal article - 2018)